Tandem Diabetes Care
TNDM
TNDM
273 hedge funds and large institutions have $2.93B invested in Tandem Diabetes Care in 2019 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 94 increasing their positions, 87 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7% more call options, than puts
Call options by funds: $59.2M | Put options by funds: $55.1M
3% less capital invested
Capital invested by funds: $3.03B → $2.93B (-$102M)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
Holders
273
Holding in Top 10
7
Calls
$59.2M
Puts
$55.1M
Top Buyers
| 1 | +$60.3M | |
| 2 | +$32.4M | |
| 3 | +$27.2M | |
| 4 |
Renaissance Technologies
New York
|
+$23.3M |
| 5 |
SIMG
Stephens Investment Management Group
Houston,
Texas
|
+$21.6M |
Top Sellers
| 1 | -$45.4M | |
| 2 | -$45.3M | |
| 3 | -$26M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$21.2M |
| 5 |
FAM
Fred Alger Management
New York
|
-$12.7M |